Authors
Latest:
Editor's Note: Are Intravenous Fluids Becoming a Commodity?With the widespread use of the intravenous route in many settings, safeguards are needed.
Latest:
Study Supports Recent Change in GINA GuidelinesA recent study demonstrated that budesonide-formoterol is superior to albuterol for as-needed exacerbation prevention in mild asthma.
Latest:
Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia InclusionEvidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.
Latest:
Job Market TrendsEmployers and pharmacy school students sometimes have differing perceptions of what it takes to successfully obtain a job in community pharmacy.
Latest:
Comparative Effectiveness of Fidaxomicin for Treatment of Clostridium Difficile InfectionOur analysis models the clinical and economic value of fidaxomicin for the treatment of Clostridium difficile infection compared with metronidazole and vancomycin.
Latest:
Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan ReexaminationMedicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.
Latest:
Avoiding Antimicrobial Misuse: Delaying the Postantibiotic EraAppropriate antimicrobial use is critical because almost 70% of bacterial infections resulting in death are resistant to at least one antimicrobial.
Latest:
CAR-NK Cell Immunotherapy Demonstrates Potential for Treating Patients With Relapsed or Refractory LymphomasPatients with relapsed/refractory leukemia and lymphomas generally have a grim prognosis, which has paved the way for immunotherapy treatments.
Latest:
Incentive Formularies: Spending and Utilization for 3 Common Drug ClassesIncentive formularies with varying cost sharing led to modestly lower overall spending, with savings for plan sponsors offset by increased out-of-pocket spending.
Latest:
Sinking the TitanicQuestions of cost and value are ones that each stakeholder group in healthcare will have to answer.
Latest:
What Lies Ahead For Pharmacists in 2021This year, pharmacists’ role will continue to evolve because of, or despite, the COVID-19 pandemic.
Latest:
Making Sense of Motivational Interviewing, Part 2: Clinical, Economic, and Other EvidenceNumerous studies have supported the use of motivational interviewing in health care to reduce cholesterol level, blood pressure, blood alcohol level, and weight.
Latest:
Spot Heart Failure a Mile AwayTelemedicine and remote monitoring advancements can help prevent hospitalizations for the condition.
Latest:
Determinants of Primary Nonadherence in Asthma-Controller and Dyslipidemia PharmacotherapyThis study linked e-prescribing records to paid pharmacy claims to identify primary nonadherence rates and factors associated with unfilled prescriptions.
Latest:
Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell CarcinomaStudy investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.
Latest:
Future of Sanofi's Inhalable Insulin in DoubtDisappointing sales were blamed on prior authorization, the FDA label restrictions, and the need for spirometry before doctors could write prescriptions.
Latest:
Aimovig Can Cut the Number of Migraine DaysThe human monoclonal antibody helps treat the painful and often debilitating condition.
Latest:
AML Genomic Landscape Plays Key Role in TreatmentNumerous therapeutic options are available for acute myeloid leukemia, but more research is needed to determine how best to use them.
Latest:
Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.
Latest:
All Pharmacies Are Not the Same: Community Pharmacy QualityPatients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.
Latest:
YouTube Can Change Public Perception of PharmacistsThe internet is an innovative way to educate people about the health care profession.
Latest:
Value-Based Design and Prescription Drug Utilization Patterns Among Diabetes PatientsChanges in antidiabetic medication cost sharing due to a value-based pharmacy access program led to increased use of generic and brand antidiabetic oral medications and insulin.
Latest:
Comparative Treatment Patterns Among Psoriasis Patients Using Adalimumab, Etanercept, or UstekinumabThis retrospective study compared the treatment patterns of ustekinumab with recommended maintenance administration every 12 weeks, with adalimumab and etanercept, administered weekly or every other week, for the treatment of plaque psoriasis.
Latest:
The Impact and Potential of Digital Health TechnologiesInnovations are expanding opportunities for care.
Latest:
Scratch Beneath the Surface: ABSSSIConsider key elements of acute bacterial skin and skin structure infection to help patients manage this broad range of diseases.
Latest:
Preventing Secondary Myocardial InfarctionEffective counseling from pharmacists can help patients with myocardial infarction to recognize symptoms and make the right treatment choices, so they can resume daily life without forgetting the importance of the rehabilitation process.
Latest:
Influx of Patients Seeking COVID-19 Boosters and Flu Shots on the HorizonThe availability of bivalent mRNA COVID-19 boosters, which provide broader protection, will likely increase vaccine demand in the fall
